C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/02 (2006.01) A61K 31/4196 (2006.01) A61K 31/506 (2006.01)
Patent
CA 2635211
Triazole derivatives of structural formula I are selective inhibitors of the 11.beta.-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other symptoms associated with NIDDM.
La présente invention concerne des dérivés de triazole de formule (I) qui sont des inhibiteurs sélectifs de la 11.beta.-hydroxystéroïde déshydrogénase-1. Les composés sont utiles dans le traitement du diabète, tel que le diabète non insulinodépendant (DNID), de l~hyperglycémie, de l~obésité, de l~insulinorésistance, de la dyslipidémie, de l~hyperlipidémie, de l~hypertension, du syndrome métabolique et d~autres symptômes associés au DNID.
Gu Xin
Kevin Nancy J.
Waddell Sherman T.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole derivatives as inhibitors of 11-beta-hydroxysteroid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole derivatives as inhibitors of 11-beta-hydroxysteroid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1596404